January 28, 2025

Heavy Cannabis Use Linked to Altered Memory Processing

New research examining 1003 young adults shows persistent reductions in working memory-related brain activation among heavy cannabis users, independent of recent use or substance dependence diagnosis.

Conexiant

January 24, 2025

VA Study Maps GLP-1 Effects Across Systems

Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.

Conexiant

January 24, 2025

Higher Cannabis Use Disorder Rates Linked to Medical Cannabis

Medical cannabis tied to increased cannabis use disorder and frequency in young U.S. adults, study finds.

Conexiant

January 22, 2025

49% of Americans Cutting Back on Alcohol

A growing number of drinking-aged Americans are interested in reducing their alcohol consumption.

Conexiant

January 16, 2025

FDA Clears First Nicotine Pouches for U.S. Market

FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 14, 2025

Construction Risks: Mental Health Tops Safety Concerns

“To say this is a crisis would be an understatement."

KFF Health News

January 08, 2025

More Archetypes to Guide OUD Discussions

Discover how a six-archetype framework enhances clinician communication, care, and decision-making for patients with opioid use disorder.

Conexiant

January 07, 2025

Acamprosate Tied to Higher Readmissions in Liver Disease

This study examines the association of acamprosate use with hospital readmission rates, abstinence, and mortality outcomes in patients with alcohol-related liver disease.

Conexiant